Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 21, 2018RSC AdvancesOpen Access

miR-425 suppresses EMT and the development of TNBC (triple-negative breast cancer) by targeting the TGF-β 1/SMAD 3 signaling pathway

View Full Paper
Ask AI
Bookmark
Share

Authors

YLYingping LiuJCJinglong Chen

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Liu et al. (2018) studied this question.

synapsesocial.com/papers/6a87b564ae2ee8767cfe72a2https://doi.org/10.1039/c8ra08872a
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1miR‐143 suppresses epithelial–mesenchymal transition and inhibits tumor growth of breast cancer through down‐regulation of ERK52015 · 58 citations
  2. 2MicroRNA-216a/217-Induced Epithelial-Mesenchymal Transition Targets Pten and SMAD7 to Promote Drug Resistance and Recurrence of Liver Cancer2013 · 387 citations
  3. 3Two Faces of TGF-Beta1 in Breast Cancer2014 · 220 citations
  4. 4A Review of Systemic Treatment in Metastatic Triple-Negative Breast Cancer2016 · 198 citations